193 related articles for article (PubMed ID: 20835917)
1. Glucagon-like peptide-1 (GLP-1) receptors are not overexpressed in pancreatic islets from patients with severe hyperinsulinaemic hypoglycaemia following gastric bypass.
Reubi JC; Perren A; Rehmann R; Waser B; Christ E; Callery M; Goldfine AB; Patti ME
Diabetologia; 2010 Dec; 53(12):2641-5. PubMed ID: 20835917
[TBL] [Abstract][Full Text] [Related]
2. Value of the radiolabelled GLP-1 receptor antagonist exendin(9-39) for targeting of GLP-1 receptor-expressing pancreatic tissues in mice and humans.
Waser B; Reubi JC
Eur J Nucl Med Mol Imaging; 2011 Jun; 38(6):1054-8. PubMed ID: 21210113
[TBL] [Abstract][Full Text] [Related]
3. Nutrient re-routing and altered gut-islet cell crosstalk may explain early relief of severe postprandial hypoglycaemia after reversal of Roux-en-Y gastric bypass.
Svane MS; Toft-Nielsen MB; Kristiansen VB; Hartmann B; Holst JJ; Madsbad S; Bojsen-Møller KN
Diabet Med; 2017 Dec; 34(12):1783-1787. PubMed ID: 28782840
[TBL] [Abstract][Full Text] [Related]
4. Histological insights into the pathogenesis of post-Roux-en-Y hyperinsulinaemic hypoglycaemia.
Lash RW; Giordano TJ; Moraitis AG; Hodish I
Diabet Med; 2014 Dec; 31(12):e29-32. PubMed ID: 25187473
[TBL] [Abstract][Full Text] [Related]
5. Utility of
Kalff V; Iravani A; Akhurst T; Pattison DA; Eu P; Hofman MS; Hicks RJ
Intern Med J; 2021 Oct; 51(10):1657-1664. PubMed ID: 33314504
[TBL] [Abstract][Full Text] [Related]
6. [Lys40(Ahx-DTPA-111In)NH2]exendin-4, a very promising ligand for glucagon-like peptide-1 (GLP-1) receptor targeting.
Wild D; Béhé M; Wicki A; Storch D; Waser B; Gotthardt M; Keil B; Christofori G; Reubi JC; Mäcke HR
J Nucl Med; 2006 Dec; 47(12):2025-33. PubMed ID: 17138746
[TBL] [Abstract][Full Text] [Related]
7. Hyperinsulinemic hypoglycemia with nesidioblastosis after gastric-bypass surgery.
Service GJ; Thompson GB; Service FJ; Andrews JC; Collazo-Clavell ML; Lloyd RV
N Engl J Med; 2005 Jul; 353(3):249-54. PubMed ID: 16034010
[TBL] [Abstract][Full Text] [Related]
8. Critical role for GLP-1 in symptomatic post-bariatric hypoglycaemia.
Craig CM; Liu LF; Deacon CF; Holst JJ; McLaughlin TL
Diabetologia; 2017 Mar; 60(3):531-540. PubMed ID: 27975209
[TBL] [Abstract][Full Text] [Related]
9. Differential effect of endogenous glucagon-like peptide-1 on prandial glucose counterregulatory response to hypoglycaemia in humans with and without bariatric surgery.
Honka H; Gastaldelli A; Pezzica S; Peterson R; DeFronzo R; Salehi M
Diabetes Obes Metab; 2024 Jun; 26(6):2476-2486. PubMed ID: 38558527
[TBL] [Abstract][Full Text] [Related]
10. Coincidence of insulinoma with nesidioblastosis or false diagnosis in 2 of 15 patients?
Goretzki PE; Starkel A
Am J Surg Pathol; 2006 Jul; 30(7):919-20; author reply 920-1. PubMed ID: 16819338
[No Abstract] [Full Text] [Related]
11. Glucagon-like Peptide-1 Receptor as Emerging Target: Will It Make It to the Clinic?
Wild D; Antwi K; Fani M; Christ ER
J Nucl Med; 2021 Jul; 62(Suppl 2):44S-50S. PubMed ID: 34230073
[TBL] [Abstract][Full Text] [Related]
12. Glucagon-like peptide-1 versus somatostatin receptor targeting reveals 2 distinct forms of malignant insulinomas.
Wild D; Christ E; Caplin ME; Kurzawinski TR; Forrer F; Brändle M; Seufert J; Weber WA; Bomanji J; Perren A; Ell PJ; Reubi JC
J Nucl Med; 2011 Jul; 52(7):1073-8. PubMed ID: 21680696
[TBL] [Abstract][Full Text] [Related]
13. PET of insulinoma using ¹⁸F-FBEM-EM3106B, a new GLP-1 analogue.
Gao H; Niu G; Yang M; Quan Q; Ma Y; Murage EN; Ahn JM; Kiesewetter DO; Chen X
Mol Pharm; 2011 Oct; 8(5):1775-82. PubMed ID: 21800885
[TBL] [Abstract][Full Text] [Related]
14. Glucagon-like peptide-1 receptor imaging for localization of insulinomas.
Christ E; Wild D; Forrer F; Brändle M; Sahli R; Clerici T; Gloor B; Martius F; Maecke H; Reubi JC
J Clin Endocrinol Metab; 2009 Nov; 94(11):4398-405. PubMed ID: 19820010
[TBL] [Abstract][Full Text] [Related]
15. Severe hypoglycaemia post-gastric bypass requiring partial pancreatectomy: evidence for inappropriate insulin secretion and pancreatic islet hyperplasia.
Patti ME; McMahon G; Mun EC; Bitton A; Holst JJ; Goldsmith J; Hanto DW; Callery M; Arky R; Nose V; Bonner-Weir S; Goldfine AB
Diabetologia; 2005 Nov; 48(11):2236-40. PubMed ID: 16195867
[TBL] [Abstract][Full Text] [Related]
16. Gastric Bypass-Related Effects on Glucose Control, β Cell Function and Morphology in the Obese Zucker Rat.
Seyfried F; Miras AD; Rotzinger L; Nordbeck A; Corteville C; Li JV; Schlegel N; Hankir M; Fenske W; Otto C; Jurowich C
Obes Surg; 2016 Jun; 26(6):1228-36. PubMed ID: 26377340
[TBL] [Abstract][Full Text] [Related]
17. Role of (68)Ga somatostatin receptor PET/CT in the detection of endogenous hyperinsulinaemic focus: an explorative study.
Prasad V; Sainz-Esteban A; Arsenic R; Plöckinger U; Denecke T; Pape UF; Pascher A; Kühnen P; Pavel M; Blankenstein O
Eur J Nucl Med Mol Imaging; 2016 Aug; 43(9):1593-600. PubMed ID: 26923247
[TBL] [Abstract][Full Text] [Related]
18. Insulinoma imaging with glucagon-like peptide-1 receptor targeting probe (18)F-FBEM-Cys (39)-exendin-4.
Xu Y; Pan D; Xu Q; Zhu C; Wang L; Chen F; Yang R; Luo S; Yang M
J Cancer Res Clin Oncol; 2014 Sep; 140(9):1479-88. PubMed ID: 24838847
[TBL] [Abstract][Full Text] [Related]
19. The focal form of persistent hyperinsulinemic hypoglycemia of infancy.
Sempoux C; Guiot Y; Rahier J
Diabetes; 2001 Feb; 50 Suppl 1():S182-3. PubMed ID: 11272187
[No Abstract] [Full Text] [Related]
20. Detection of the human glucagon-like peptide 1(7-36) amide receptor on insulinoma-derived cell membranes.
Lankat-Buttgereit B; Göke R; Stöckmann F; Jiang J; Fehmann HC; Göke B
Digestion; 1994; 55(1):29-33. PubMed ID: 8112494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]